All News

Data from the study shows a strong immune response in this age group following this dose, with no new safety signals.

FT218 is an investigational formulation of sodium oxybate that is designed to be taken once at bedtime for the treatment of excessive daytime sleepiness for individuals with narcolepsy.

Investigators observe strong immunogenicity profile in study participants aged 5 to 17 years 1 month after the primary vaccination series.

Cabotegravir inhibits HIV integrase by binding to the integrase active site and blocking the strand transfer step of retroviral DNA integration.

Pharmacists can potentially improve the health and quality of life of millions of people by staying up to date with advancements in migraine treatments.

They added that policy decisions around preventing and treating health conditions is important and should account for the indirect costs of the conditions as well.

Hogue is the second pharmacist to ever serve on the advisory committee.

Acute graft-versus-host disease (aGVHD) is the most frequently encountered, life- threatening complication following an allogeneic hematopoietic stem cell transplant (aHSCT).

This month's generic product new features dexmethylphenidate, colchicine, and clarithromycin.

Ravulizumab-cwvz (Ultomiris) is the first and only long-acting C5 complement inhibitor for the treatment of generalized myasthenia gravis to gain FDA approval.

This month's OTC case studies focuses on asthma.

Scemblix is indicated for Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase, previously treated with 2 or more tyrosine kinase inhibitors.

Pedialyte replaces fluids, electrolytes, and minerals lost from diarrhea and vomiting.

Thiazolidinediones may change metabolic patterns and contribute to weight gain.

Individuals with diabetes, a higher body mass index, or a history of hospitalization are more likely to develop the condition, the analysis shows.

Of these visits, approximately 11%, or 8 million, resulted in antibiotic prescriptions, foremost commonly for illnesses that are not caused by a bacterial infection, such as bronchitis, non-bacterial skin conditions, and viral respiratory-tract infections.

Evusheld concentrations remained elevated in serum for 6 months after administration, supporting that a single dose could provide long-term protection against COVID-19.

Almost all the participants who had not had COVID-19 seroconverted after vaccination, meaning they made antibodies against the virus.

Telehealth use expanded in the pharmacy during the pandemic, however, pharmacy personnel face challenges when implementing these services, beginning with regulatory requirements.

The data show that the 10-year survival rate of patients with breast cancer who survived Hurricane Katrina was much lower than those who did not face a major weather event.

Two-thirds of women diagnosed with endometrial cancer have localized disease and a 5-year relative survival of 95%.

Because pharmacists are one of the most accessible health care providers, we are trained in medication selection and in how to counsel patients who wish to stop smoking.

Up to 50% of all patients with breast cancer have tumors with a HER2 immunohistochemistry level not currently eligible for HER2-targeted therapy.

Brought to you by The Sassy Pharmacist

Oncologists and rheumatologists reported the highest costs to their practices at $6700 and $7900 per month, respectively.

This month's Rx product new features Cabotegravir and Rilpivirine, Fleqsuvy, and Enjaymo.

Finasteride (Propecia) is a 5α-reductase inhibitor indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men only.

OTC levocetirizine dihydrochloride antihistamine is indicated for allergy symptoms, such as runny nose and sneezing.

With Epsolay treatment, inflammatory lesions of rosacea were reduced by nearly 70% by the end of both 12-week trials compared with a 38% to 46% reduction with the vehicle cream.

Of the 53 pediatric patients enrolled in the CARAVAN study, no new safety signals were apparent for patients treated with remdesivir.